Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TTMI vs GSK✓SelectedUSD · GSKTTMI vs GSK performance historyLatest closeAs of-13.46%11/20
Stock and ETF performance explorer

TTMI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+308.7%
GSK return
+53.4%
Excess return
+255.3%
Maximum drawdown
-73.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-13.5%-0.1%-13.3%-13.5%
7D-20.6%-5.3%-15.2%-21.6%
30D-42.4%-3.7%-38.7%-42.6%
3M-48.5%-7.3%-41.3%-48.7%
6M-65.3%-4.2%-61.0%-65.2%
YTD-14.7%+0.9%-15.6%-14.0%
1Y+0.7%+7.3%-6.6%+1.7%
3Y+308.7%+52.7%+255.9%+318.1%
All+308.7%+53.4%+255.3%+318.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling